Some say left ventricular intracardiac echogenic focus (ICEF) in the second trimester may signal the presence of Down syndrome.
Some say left ventricular intracardiac echogenic focus (ICEF) in the second trimester may signal the presence of Down syndrome. Others believe you can ignore it in an otherwise healthy normal fetal heart. Starting out with 62 cases of ICEF among patients who also had a triple marker screen performed, researchers from the University of Illinois at Chicago found that none of the cases with a negative triple screen and no other cardiac abnormalities (58/62 or 93.5%) had trisomy 21. Put another way, you can probably tell patients with isolated ICEF on a 2nd-trimester U/S, plus a negative triple screen, that the risk of Down syndrome is "not increased above their age-related risk."
Kemp A, Colon M. The significance of a fetal intracardiac echogenic focus in the face of normal triple-marker testing. Obstet Gynecol. 2005;105(4 suppl):52S.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More